do glp 1 cause pancreatic cancer GLP-1 Risk: What New Data Reveal GLP-1 Receptor Agonists: Benefits and

After bariatric or stomach surgery, resuming GLP-1 therapy requires extra care because your new stomach anatomy affects medication absorption and side effect risk

It mainly affects the motor nervous system, and is associated with the loss of Lewy bodies and substantia nigra dopamine neurons (55)

Research, including recent findings from the SELECT trial, indicates that GLP-1 agonists like semaglutide can significantly reduce the risk of major cardiovascular events, such as heart attacks and strokes, especially in individuals with obesity but without diabetes

In July 2023, the European Medicines Agency 206 and the UK Medicines and Healthcare products Regulatory Agency (MHRA) 230 started a review of these medications safety following reports of worsening mood and suicidal behavior observed in GLP-1RA users